LIS
VRTX icon

Legacy Investment Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Legacy Investment Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$29.4K Buy
+66
New +$30.4K 0.02% 205
2024
Q4 		$31.4K Buy
67
+1
+2% +$464 0.02% 158
2024
Q3 		$32.6K Buy
+66
New +$31.7K 0.02% 151

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Legacy Investment Solutions's VRTX Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2025: 66 shares worth $29.4K. The stake represents 0.02% of the portfolio and ranks #205 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in VRTX as recently as Q4 2024.

Legacy Investment Solutions first reported a position in VRTX in Q3 2024 and has held it in 3 quarters since. The position peaked at $32.6K in Q3 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Legacy Investment Solutions held 66 shares of Vertex Pharmaceuticals worth $29.4K as of Q2 2025.
  • Vertex Pharmaceuticals was a new Legacy Investment Solutions position in Q2 2025.
  • Vertex Pharmaceuticals made up 0.02% of Legacy Investment Solutions's portfolio in Q2 2025, its #205 holding.
  • Legacy Investment Solutions first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Vertex Pharmaceuticals position peaked at $32.6K in Q3 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.